Ninety One UK Ltd cut its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) by 5.2% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 32,526 shares of the medical instruments supplier’s stock after selling 1,800 shares during the period. Ninety One UK Ltd’s holdings in West Pharmaceutical Services were worth $10,714,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds have also made changes to their positions in WST. Evoke Wealth LLC purchased a new position in West Pharmaceutical Services in the fourth quarter valued at about $7,770,000. Sumitomo Mitsui Trust Holdings Inc. increased its position in West Pharmaceutical Services by 1.5% during the 1st quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 191,469 shares of the medical instruments supplier’s stock valued at $75,766,000 after buying an additional 2,759 shares in the last quarter. Vanguard Group Inc. raised its stake in West Pharmaceutical Services by 1.2% in the fourth quarter. Vanguard Group Inc. now owns 9,002,632 shares of the medical instruments supplier’s stock valued at $3,170,007,000 after buying an additional 104,740 shares during the last quarter. Mizuho Markets Americas LLC grew its stake in shares of West Pharmaceutical Services by 142.3% during the first quarter. Mizuho Markets Americas LLC now owns 29,628 shares of the medical instruments supplier’s stock worth $11,724,000 after acquiring an additional 17,399 shares during the last quarter. Finally, Hsbc Holdings PLC raised its position in shares of West Pharmaceutical Services by 39.8% in the 4th quarter. Hsbc Holdings PLC now owns 138,468 shares of the medical instruments supplier’s stock valued at $48,750,000 after purchasing an additional 39,392 shares during the last quarter. 93.90% of the stock is currently owned by hedge funds and other institutional investors.
West Pharmaceutical Services Stock Performance
WST stock traded down $0.99 during trading on Tuesday, reaching $300.69. The company had a trading volume of 59,230 shares, compared to its average volume of 568,094. The company has a market cap of $21.81 billion, a price-to-earnings ratio of 39.80, a price-to-earnings-growth ratio of 10.68 and a beta of 1.00. West Pharmaceutical Services, Inc. has a twelve month low of $265.00 and a twelve month high of $415.73. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.68 and a current ratio of 2.34. The firm has a 50-day simple moving average of $314.46 and a 200-day simple moving average of $349.20.
Insider Activity at West Pharmaceutical Services
In other West Pharmaceutical Services news, SVP Silji Abraham sold 1,800 shares of West Pharmaceutical Services stock in a transaction dated Wednesday, June 12th. The stock was sold at an average price of $330.78, for a total transaction of $595,404.00. Following the completion of the transaction, the senior vice president now owns 2,860 shares in the company, valued at approximately $946,030.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.53% of the stock is currently owned by insiders.
West Pharmaceutical Services Company Profile
West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.
Featured Stories
- Five stocks we like better than West Pharmaceutical Services
- How to Use the MarketBeat Stock Screener
- Columbia Sportswear: A Turnaround Story That’s Gaining Ground
- The Most Important Warren Buffett Stock for Investors: His Own
- Lowe’s Stock: Hold Now, Buy it When it Dips
- Golden Cross Stocks: Pattern, Examples and Charts
- ZIM Shipping Stock Soars as the Industry Shows a Bottoming Trend
Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.